ArticleFrontiers in aging neuroscience2026
The association between body composition and orthostatic hypotension in patients with neurodegenerative disorders in parkinsonism-related multidisciplinary clinic.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Orthostatic hypotension (OH) commonly impairs the quality of life and prognosis of patients with neurodegenerative disorders. Since skeletal muscle functions as a peripheral pump for blood pressure stabilization and a reservoir for intracellular water, we investigated its association with body composition in these patients. Methods: This prospective cross-sectional study included 86 patients with neurodegenerative disorders from Parkinsonism-related Multidisciplinary Clinic in Peking Union Medical College Hospital (PUMCH), including multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and other atypical parkinsonian syndromes (APS). OH was defined as a sustained reduction in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mmHg within 3 min of active standing. Participants were divided into with OH and without OH (non-OH). Body composition was measured via Bioelectrical Impedance Analysis (BIA). The measured values were normalized to height squared to generating indices such as the fat-free mass index (FFMI) and appendicular muscle mass index (AMI). Clinical scores, levodopa equivalent daily dosage (LEDD), and grip strength were compared between groups. Sarcopenia was diagnosed according to the Asian Working Group for Sarcopenia 2019 (AWGS2019) criteria. Results: The incidence of OH was 45.3%, significantly higher in MSA (58.0%) than in PSP (13.3%). Sarcopenia prevalence did not differ significantly between groups. Elastic net and support vector machine (SVM) analysis identified lower limb extracellular water index (LLEWI) and AMI as the most predictive body composition indicators for OH. Linear regression confirmed AMI as an independent negative predictor of orthostatic systolic blood pressure change ( Conclusion: Our findings indicate that OH is significantly associated with decreased AMI and lower LLEWI. Measuring these indices may offer valuable insights into OH risk, potentially serving as a more sensitive early indicator than a formal diagnosis of sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.